Intravenous Human Albumin In Improving Pancreaticoduodenectomy Outcomes
Status:
Recruiting
Trial end date:
2022-11-26
Target enrollment:
Participant gender:
Summary
Pancreaticoduodenectomy (PD), more commonly known as Whipple's surgery is the mainstay
treatment for pancreatic head and periampullary cancer. Factors contributing to PD outcomes
are broadly categorized to disease-related, patient-related and operative factors. Whereas an
inexhaustible list of study exists on looking at reducing PD complication rates with respect
to the above-mentioned factors, it was only recently that more attention has been given to
the impact of perioperative and intraoperative fluid regimes on PD outcomes. This study takes
interest in the impact of intraoperative fluid regimes on PD outcomes. The objective of this
investigation is to compare the outcomes with the use of intraoperative intravenous human
albumin versus standard intraoperative fluid regimes.